Belpointe Asset Management LLC
- SEC CIK
- 0001721242
- Latest filing
- Jul 31, 2026
ESPR holding history
Esperion Therapeutics, Inc. in every 13F filed by Belpointe Asset Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ESPR overviewAll 13F holders of ESPRFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −38,000−100.0% | Sold out | Holders |
| Q1 2025 | 38,000 | $54.7K | <0.1% | −9,000−19.1% | Reduced | Holders |
| Q4 2024 | 47,000 | $86.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 47,000 | $77.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 47,000 | $104.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 47,000 | $126.0K | <0.1% | +47,000 | New | Holders |